Mayne Pharma reported AUD1.29B in Assets for its first fiscal semester of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Assets Change
Ansell ANN:AU USD 2.51B 75.9M
Cochlear COH:AU AUD 2.47B 33.1M
CSL CSL:AU USD 28.35B 4.91B
Ecofibre Ltd EOF:AU AUD 149.55M 7.64M
Healius Ltd HLS:AU AUD 4.14B 216.6M
Integral Diagnostics Ltd IDX:AU AUD 783.02M 66.41M
Medical Developments International Ltd MVP:AU AUD 96.02M 4.15M
Nanosonics Ltd NAN:AU AUD 187.67M 16.44M
Next Science Ltd NXS:AU USD 19.08M 5.36M
Polynovo Ltd PNV:AU AUD 34.97M 1.62M
Probiotec Ltd PBP:AU AUD 237.91M 18.88M
Ramsay Health Care RHC:AU AUD 19.47B 2.32B
ResMed RMD:AU USD 5.1B 190.59M
Sigma Healthcare Ltd SIG:AU AUD 1.18B 71.34M
Sonic Healthcare SHL:AU AUD 12.55B 87.82M
Telix Pharmaceuticals Ltd TLX:AU AUD 215.94M 106.13M